[ET Net News Agency, 29 December 2025] EVEREST MED (01952) fell 10% to HK$40.14.
It hits an intra-day low of HK$40.08, hitting an 1-month low, and an intra-day high of HK$44.78. The total shares traded was 4.87 million, with a value of HK$204.75m. The active buy/sell ratio is 36:64, with net selling turnover of HK$53.03m. CHINA INV INFO accounts for greatest net responsive buying turnover of HK$9.51m, with volume weighted average price of HK$42.261. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$1.97m, with volume weighted average price of HK$41.823. The stock has fallen a combined 18.1% over the past 4 consecutive trading days.
Basic Information| Nominal | 40.140 | % Chg | -10.04% |
| High | 44.780 | Low | 40.080 |
| Shares Tr | 4.87m | Turnover | 204.75m |
| 10-D SMA | 46.372 | %H.V | 43.869 |
| 20-D SMA | 45.661 | VWAP | 42.005 |
| 50-D SMA | 46.851 | RSI14 | 33.502 |
Status: Hitting an 1-month low, active buy/sell ratio is 36:64, with net selling turnover of HK$53.03m, falling a combined 18.1% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| EVEREST MED (01952) | 40.14 | -10.04 |
| SINO BIOPHARM (01177) | 6.34 | -1.25 |
| 3SBIO (01530) | 25.40 | -1.85 |
| WUXI XDC (02268) | 63.20 | +0.24 |
| ASCENTAGE-B (06855) | 51.90 | -3.17 |
| SKB BIO-B (06990) | 399.40 | -4.72 |
| DUALITYBIO-B (09606) | 304.40 | -2.75 |
| ZAI LAB (09688) | 14.06 | -2.90 |
| AKESO (09926) | 111.60 | -0.89 |
| REMEGEN (09995) | 75.00 | -1.32 |
(ed)
